Despite the hoopla, the accuracy of CRISPR-based approaches has raised concerns among academics, clinicians and regulators. The ability...

Recognition of cancer's heterogeneity is not new. But time and again when looking at clinical trial designs and even preclinical modeling...

In questioning the health benefit of wearables, the article below touches upon some recent positive trends.  For instance, insurers...

Non-alcoholic Steatohepatitis (NASH), although one of the leading causes for liver transplant is a mostly forgotten disease. Despite...

The Human Microbiome Project was launched by the National Institutes of Health in 2007 yet there is still much to be known about...

The curious habit of vomiting its viscera at predators may mean the lowly sea cucumber holds the key to a clearer understanding of the...

CAR-T therapies are one of the most recently developed revolutionary cancer treatments and certainly one of the most hyped innovations in...

Recent research has found correlation between someone undergoing major depressive episodes with neuroinflammation based on microglial...

“How will AI change strategy?” The opening line to an interesting thought experiment written by the Harvard Business Review. In the...

Immuno-oncology has seen a rapid growth in the past few years in terms of not only research, clinical development and investment but also...

The microbiome, the complex community of micro-organisms such as bacteria, fungi, and viruses and their genes is a hot topic at the moment.

Qiagen, a sample to insight molecular testing company, has joined forces with Centogene, owners of CentoMD. CentoMD is the largest...

The FDA awarded $22 million across 15 clinical trial grants to help increase rare disease drug development. Fantastic! But is it enough?

A...

After turning its attention from home delivery of almost anything you can imagine, perhaps it's not surprising that media reports are...

Optogenetics, a technique which involves the use of light to control neurons, has been successfully used in mice to restore stability...

A recent report published in The Lancet calls for a coordinated strategy to reform the science and policy behind stem cells and...

The UK health industry is fuelled by pioneers. It may not always seem it, but through every sector of health, there are industrious...

NEJM article makes a case for a fresh approach to design and interpretation of noninferiority trials in the context of today's...

Discoveries around genomics and partnerships related to genomic data have recently been making headlines with Sophia Genetics raising $30...

Adrenoleukodystrophy (ALD) is a rare hereditary mutation and neurodegenerative disease that affects about 0.005% of young boys, and has...

It seems to be the thing we are all talking about and breaking down the barriers can only be a good thing. However it must be noted that...

Medical implants are typically not designed for pediatrics. This is partially due to current implant technologies inability to...

The mapping of the genome is considered to be one of the greatest medical advances of the 21st century so far. It is easy to see why,...

The UK Royals have pledged £2 million to a new digital mental health initiative. Celebrities are speaking out about their challenges with...

Myleodysplastic syndromes (MDS) affects haematopoiesis within its sufferers, this leads to severe anaemia. Currently the way that the...

There is considerable interest and excitement about the human microbiome, the complex community of micro-organisms such as bacteria,...

A great glimpse into of some the stimulating conversations among pharma innovation leaders this past week at the Health 2.0 Annual Fall...

Treating autoimmune disorders has been a cash cow for several pharmaceutical companies, with biologics and biosimilars dominating pharma...

Cost pressures, ongoing consolidation, increasing sophistication of customers, and digitalization of health care present unprecedented...

News of Alnylam's experimental RNAi drug thrilled both patients and scientists, who have been working for over a decade to create a drug...

Though CRISPR/Cas9 has shown great potential for genetic modification in various therapies, deliverying the platform has been a key...

Back in April 2003, the Human Genome Project, which was one of the great feats of exploration in human history, was completed. This...

It has been a year filled with innovation and exciting technology in the healthcare sector. From the focus on CRISPR to the first...

The emergent success of immune-oncology (IO) drug approvals in multiple tumours has appointed it as the fifth pillar in cancer treatment.

“The microbiome: opportunity or hype?” - My latest iPhone notification reflects the daily evolution of our industry:  increased...